As part of its ongoing commitment to empowering the next generation talents, MS Pharma proudly participated in two leading university job fairs this May—reinforcing its mission to improve communities’ quality of life through innovation, opportunity, and purpose-driven careers.

Under the patronage of His Excellency the Saudi Minister of Industry and Mineral Resources, Mr. Bandar AlKhorayef, MS Pharma inaugurated Saudi Arabia’s first biologics manufacturing facility, with formulation, fill & finish capabilities—marking a groundbreaking step towards pharmaceutical localization and healthcare independence in the Kingdom of Saudi Arabia and the wider MENA region.

As part of its strategic expansion in specialty care and biopharmaceutical innovation, MS Pharma convened its 1st Annual Biosimilar Summit in Dubai, United Arab Emirates, under the theme "Legacy Illuminated". The event brought together more than 110 retina specialists from 70 institutions across 15 countries, underscoring MS Pharma’s role as a growing leader in advancing biosimilar science and access in the MENA region.

As part of its ongoing commitment to health, safety, and operational excellence, MS Pharma celebrated World Safety Day 2025 across its facilities, including United Pharmaceutical Manufacturing and MS Pharma Injectables in Jordan, MS Pharma in Saudi Arabia, and El-Kendi in Algeria. This initiative reaffirms MS Pharma’s belief that safety is not merely a workplace obligation, but a core value embedded in every process, decision, and action across the organization.

Riyadh, Saudi Arabia 10/12/2024— MS Pharma, a leader in pharmaceutical innovation across the Middle East and North Africa, showcased its cutting-edge biologics portfolio and state-of-the-art biosimilar manufacturing facility at CPhI Middle East 2024. The event, held from December 10–12 at the Riyadh Front Exhibition & Convention Center, is recognized as the premier gathering for global pharmaceutical leaders.